Independent Panel Study Of Guidant Will Help Beyond ICDs – Panel Chair
This article was originally published in The Gray Sheet
Executive Summary
An independent panel created by Guidant will produce a case study on the company's recent handling of implantable cardioverter defibrillator safety communications by February 2006, according to panel chair Robert Myerburg, MD, University of Miami
You may also be interested in...
Guidant Focused On Trend Thresholds Instead Of Preventable Deaths – Panel
Guidant has relied too much on engineers and not enough on physicians in evaluating the postmarket performance of its implantable cardiac rhythm management products, making it possible for device problems to go unaddressed, according to an expert panel commissioned by the company
Guidant Focused On Trend Thresholds Instead Of Preventable Deaths – Panel
Guidant has relied too much on engineers and not enough on physicians in evaluating the postmarket performance of its implantable cardiac rhythm management products, making it possible for device problems to go unaddressed, according to an expert panel commissioned by the company
Physicians Implanting ICDs, Pacers Need Education On Reliability – HRS Docs
The Heart Rhythm Society should work with FDA and manufacturers to educate physicians on realistic expectations for ICD and pacemaker performance, according to participants at the Policy Conference on Pacemaker and ICD Performance